DNA

Key Statistics

Latest News

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

PR Newswire 1 day ago

Ginkgo Bioworks Holdings Inc (DNA) Q4 2025: Everything You Need To Know Ahead Of Earnings

GuruFocus.com 2 days ago

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation

PR Newswire Feb 19, 2026

Ginkgo Bioworks Signs Crop Protection Collaboration With Invaio

MT Newswires Feb 18, 2026

Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products

PR Newswire Feb 18, 2026

Community Sentiment

Sign in to vote

0 votes

Discussion (0)

About Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.